PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human Endostatin (carrier-free), 25 µg
Recombinant Human Epigen (carrier-free), 100 µg
Recombinant Human Epigen (carrier-free), 25 µg
Recombinant Human Epigen (carrier-free), 500 µg
Recombinant Human Epiregulin (carrier-free), 25 μg
Recombinant Human Erythropoietin (EPO) (carrier-free), 10 μg
Recombinant Human Erythropoietin (EPO) (carrier-free), 100 μg
Recombinant Human Erythropoietin (EPO) (carrier-free), 25 μg
Recombinant Human Erythropoietin (EPO) (carrier-free), 500 μg
Recombinant Human E-Selectin (CD62E)-Fc Chimeric (carrier-free), 10 μg
Recombinant Human E-Selectin (CD62E)-Fc Chimeric (carrier-free), 25 μg
Recombinant Human FAS (TNFRSF6)-Fc Chimera (carrier-free), 100 μg
Recombinant Human FAS (TNFRSF6)-Fc Chimera (carrier-free), 25 μg
Recombinant Human FAS (TNFRSF6)-Fc Chimera (carrier-free), 500 μg
Recombinant Human FASL (TNFSF6) (carrier-free), 10 μg
Recombinant Human FASL (TNFSF6) (carrier-free), 100 μg